Home > News > DNA-Based Nanoengine for On-Demand Drug Release
August 15th, 2005
DNA-Based Nanoengine for On-Demand Drug Release
Abstract:
Nucleic acid aptamers are small pieces of DNA or RNA designed not to convey genetic information but to bind tightly to specific proteins and other biological molecules. Numerous investigators have used aptamers as replacements for antibodies in various therapeutic and diagnostic applications, and now a team at McMaster University has found a third use for these versatile molecules as the heart of a DNA-protein nanoengine that can be programmed to release therapeutically useful molecules in response to a programmed molecular signal.
Source:
nano.cancer.gov
Bookmark:
| Related Links |
| Related News Press |
Molecular Machines
First electric nanomotor made from DNA material: Synthetic rotary motors at the nanoscale perform mechanical work July 22nd, 2022
Nanotech scientists create world's smallest origami bird March 17th, 2021
Giant nanomachine aids the immune system: Theoretical chemistry August 28th, 2020
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||